Trial Identifier: | D822EC00001 |
Sponsor: | AstraZeneca |
NCTID:: | NCT05665374 |
Start Date: | June 2023 |
Primary Completion Date: | May 2026 |
Study Completion Date: | May 2026 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
Japan | Chiba, Japan |
Japan | Kyoto, Japan |
Japan | Kyoto, Japan |
Japan | Kyoto, Japan |
Japan | Kyoto, Japan |
Japan | Kyoto, Japan |
Japan | Kyoto, Japan |
Japan | Kyoto, Japan |
Japan | Kyoto, Japan |
Japan | Kyoto, Japan |
Japan | Kyoto, Japan |
Japan | Miyazaki, Japan |
Japan | Nagano, Japan |
Japan | Nara, Japan |
Japan | Oita, Japan |
Japan | Okayama, Japan |
Japan | Osaka, Japan |
Japan | Tokyo, Japan |